Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2006
10/17/2006US7122196 Compounds and methods for diagnosis of tuberculosis
10/17/2006US7122190 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells
10/17/2006US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody
10/17/2006US7122184 Monoclonal antibody for use in prevention of fungal infections
10/17/2006US7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L
10/17/2006US7122154 Apparatus for testing breath alcohol with discrimination between alveolar and upper respiratory tract alcohol
10/17/2006US7122152 Spatiotemporal and geometric optimization of sensor arrays for detecting analytes fluids
10/17/2006US7122111 Sample discriminating method
10/17/2006US7121519 Silicone mould tool
10/17/2006US7121149 Gyratory compactor apparatus and associated devices and methods
10/17/2006US7121135 Method and device for determining the permeation of a barrier layer
10/17/2006US7121134 Integrated sample cell and filter and system using same
10/17/2006CA2419700C Parallel reactor with internal sensing and method of using same
10/17/2006CA2359659C Method for quality control of an attenuated varicella live vaccine
10/17/2006CA2342141C Method for detection of legionella bacteria employing purified antigen-specific antibodies
10/17/2006CA2250090C Method of assaying compressive strength of rock
10/17/2006CA2177179C Antagonists to chaperonin 10
10/17/2006CA2150497C Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase
10/13/2006CA2522413A1 Markers for sudden death in heart failure
10/12/2006WO2006108180A2 Thin film coated microwell arrays and methods of making same
10/12/2006WO2006108130A2 Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin a complexes in a blood sample
10/12/2006WO2006108095A2 Serum biomarker for disease and methods of using same
10/12/2006WO2006108033A2 Recombinant antigens for the detection of coxiella burnetii
10/12/2006WO2006107972A2 Permittivity based detection of immunobiological specific bindings in a capacitive cell of coplanar waveguide or microstrip layout using a microwave
10/12/2006WO2006107864A1 Screening using polarization anisotropy in fret emissions
10/12/2006WO2006107846A2 Biomakers of liver injury
10/12/2006WO2006107666A2 Body fluid testing component for analyte detection
10/12/2006WO2006107506A2 System and method for performing g protein coupled receptor (gpcr) cell assays using waveguide-grating sensors
10/12/2006WO2006107421A2 Preparation of platelet analogs
10/12/2006WO2006107371A1 Diagnostic test kits employing an internal calibration system
10/12/2006WO2006107370A1 Technique for detecting microorganisms
10/12/2006WO2006107331A1 Coated composites of magnetic material and quantum dots
10/12/2006WO2006107312A1 Nanosensors
10/12/2006WO2006107198A2 Production of unconjugated oligosaccharides by pathogens
10/12/2006WO2006107078A1 Method of assessing effectiveness of interferon therapy and kit for assessing the same
10/12/2006WO2006107031A1 Method of relative risk for the onset of atopic dermatitis by gene single nucleotide polymorphism analysis
10/12/2006WO2006106976A1 Method of assaying antibody against cell membrane surface antigen
10/12/2006WO2006106957A1 Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same
10/12/2006WO2006106950A1 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
10/12/2006WO2006106930A1 NUCLEIC ACID PROBE CONTAINING Eu3+ COMPLEX AND METHOD OF ANALYZING NUCLEIC ACID BY USING THE SAME
10/12/2006WO2006106912A1 Cancer-associated antigen analog peptide and utilization of the same
10/12/2006WO2006106870A1 Method of dispensing in reaction vessel and reaction vessel processing apparatus
10/12/2006WO2006106868A1 Method of dispensing nonvolatile liquid in reaction vessel and reaction vessel processing apparatus
10/12/2006WO2006106823A1 Method for distinguishing mesenchymal stem cell using molecular marker and use thereof
10/12/2006WO2006106752A1 Noninvasive analysis method
10/12/2006WO2006106741A1 Bioreaction execution apparatus, method of bioreaction execution, dna chip, information processing unit, method of information processing, program and recording medium
10/12/2006WO2006106695A1 Highly sensitive hematological assay and reagent
10/12/2006WO2006106678A1 Boron absorption-promoting gene
10/12/2006WO2006106661A1 Method for display of determination information of biologically relevant substance
10/12/2006WO2006106598A1 Method of evaluating renal disease activity and apparatus therefor
10/12/2006WO2006106340A2 Formation of aggregates in enzyme assays
10/12/2006WO2006106193A1 Method for obtaining soluble or better expressed variants of a protein of interest
10/12/2006WO2006106148A1 Measuring specific activity of glyoxalase i as novel diagnostic/prognostic tool in diabetes pathology and aging processes
10/12/2006WO2006106129A2 Polypeptide markers for the diagnosis of prostate cancer
10/12/2006WO2006106115A2 Polypeptide marker for diagnosing alzheimer's disease
10/12/2006WO2006106004A1 Sensor module, in particular for an air conditioning system
10/12/2006WO2006105985A1 Reversible sequential binding assays
10/12/2006WO2006105907A1 Neurodegenerative markers for psychiatric conditions
10/12/2006WO2006105777A1 Method for obtaining primary-culture tumour cells from tumour tissue, in particular breast carcinoma, primary-culture tumour cells and their use
10/12/2006WO2006105665A1 Hydrogel composition for modulation of topical inflammatory response
10/12/2006WO2006105653A1 Method and system for identification of antigen
10/12/2006WO2006105650A1 Method for cancer detection and monitoring
10/12/2006WO2006087637A3 Anti her2/neu antibody
10/12/2006WO2006087220A3 Receptacle for the separation of tumor cells
10/12/2006WO2006086873A8 Method for determining native wood constituents using visible-light raman spectrometry
10/12/2006WO2006086859A3 Method and kit to profile tumours by biomarker analyses including transcriptional factor assays
10/12/2006WO2006084299A8 Method for evaluating the allergen sensitivity of an individual
10/12/2006WO2006063734A3 Integrin (alpha v beta 1) as target/marker for insulin resistance
10/12/2006WO2006059268A3 A method for calibrating a transfer function of a magnetic sensor
10/12/2006WO2006056365A3 Method for identification and analysis of measuring values obtained with the aid of an analysis device from a multi-component mixture of materials in variable environmental conditions
10/12/2006WO2006052566A3 Gpr41 and modulators thereof for the treatment of insulin-related disorders
10/12/2006WO2006050214A3 Method and system for providing online authentication using biometric data
10/12/2006WO2006044747A3 P27 ubiquitination assay and methods of use
10/12/2006WO2006036212A3 Non-sugar sweeteners for use in test devices
10/12/2006WO2006034354A3 Methods of diagnosing and treating vhl associated tumors and sporadic renal cell carcinoma, other vhl sporadic counterpart tumors and non-tumor lesions which co-express epo and the epo receptor
10/12/2006WO2006033742A3 Engineered antibody fragment that irreversibly binds an antigen
10/12/2006WO2006012507A3 Methods and compositions for risk stratification
10/12/2006WO2006006113A9 Microlaboratory for biological fluids analysis using white light illumnation
10/12/2006WO2006002382A3 Arrays with cleavable linkers
10/12/2006WO2005123774A3 Antibodies to west nile virus polypeptides
10/12/2006WO2005116263A3 Methods for rapid forensic analysis of mitochondrial dna
10/12/2006WO2005114191A3 Method for a fully automated monoclonal antibody-based extended differential
10/12/2006WO2005086611A3 Methods of precise molecular-level determination of ligand-receptor interactions and designing selective drug compounds based on said interactions
10/12/2006WO2005069220A3 Method for mapping defects on leather
10/12/2006WO2005069004A3 Solid-supported membranes inside porous substrates and their use in biosensors
10/12/2006WO2005051320A3 Gcks as modifiers of branching morphogenesis and methods of use
10/12/2006WO2005044792A3 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
10/12/2006WO2005016527A3 Non-pressure based fluid transfer in assay detection systems and related methods
10/12/2006WO2005012479A3 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
10/12/2006WO2004083389A3 Mbcats as modifiers of the beta-catenin pathway and methods of use
10/12/2006WO2003073821A3 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER
10/12/2006US20060230469 Method and means for determining fitness in plants
10/12/2006US20060230466 Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof
10/12/2006US20060230465 K203 gene and protein
10/12/2006US20060229547 Systems and methods for collecting leukocyte-reduced blood components, including plasma that is free or virtually free of cellular blood species
10/12/2006US20060229533 Integrated test element
10/12/2006US20060229502 Portable medical diagnostic apparatus
10/12/2006US20060229470 Calcium receptor-active molecules
10/12/2006US20060229444 Can be used for identifying mu3 opiate receptor agonists and antagonists
10/12/2006US20060229334 Biphenyl derivatives